GlassScriptPhysician profile
David J Rodriguez
NPI 1306963335
$5,932.08
in general payments reported to CMS, 2019-2025
29 companies · $979 in 2025
The $979 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,072 · 2020: $610 · 2021: $421 · 2022: $558 · 2023: $612 · 2024: $680 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,253 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,252.59 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,711.12 | 2019 | |
| Amgen INC. | $703.10 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $698.32 | 2019-2025 | Lifevest |
| Abbott Laboratories | $570.69 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $408.22 | 2022-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $287.65 | 2020-2025 | Impella |
| Teleflex LLC | $180.89 | 2023-2025 | Guideliner, Turnpike |
| Medtronic, INC. | $171.66 | 2023-2025 | Micra, In.Pact Admiral |
| Shockwave Medical, INC | $146.81 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $146.41 | 2023 | Indigo System |
| Cardiva Medical, INC. | $121.45 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biosense Webster, INC. | $117.40 | 2022 | |
| Ablative Solutions, INC. | $109.70 | 2022 | |
| Kestra Medical Technology Services, INC. | $73.43 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $71.31 | 2019-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $60.61 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $40.88 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.77 | 2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $38.00 | 2024 | Arcalyst |
| Chiesi USA, INC. | $36.41 | 2024 | Cleviprex, Kengreal |
| Stryker Corporation | $35.43 | 2025 | Flowtriever |
| Pfizer INC. | $27.99 | 2019-2024 | |
| Tactile Systems Technology INC | $24.90 | 2025 | Nimbl, Flexitouch Plus |
| Novo Nordisk INC | $24.82 | 2024 | Wegovy |
| Angiodynamics, INC. | $23.20 | 2020 | |
| Inari Medical, INC. | $17.87 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $16.35 | 2024 | Onpattro |
| Sanofi-Aventis U.S. LLC | $15.57 | 2019 | |
| Ekos Corporation | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.